News from insmed incorporated A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

May 10, 2011, 07:00 ET Insmed Announces First Quarter 2011 Financial Results

Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company, today reported results for the first quarter ended March 31, 2011. Key Recent...


Apr 26, 2011, 08:00 ET Insmed to Host 2011 First Quarter Earnings Conference Call

Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company, will host a conference call on Tuesday, May 10th, 2011, at 8:30 AM ET, to discuss ...


Mar 21, 2011, 08:15 ET Insmed Announces FDA Clearance of IND for Pivotal Phase 3 Trial of ARIKACE™ in Nontuberculous Mycobacteria Indication

Insmed Incorporated (Nasdaq: INSMD), a biopharmaceutical company, announced today that the Company's Investigational New Drug Application (IND) to...


Mar 21, 2011, 08:00 ET Insmed Regains NASDAQ Compliance

Insmed Incorporated (Nasdaq CM: INSMD), a biopharmaceutical company, today announced that it has received notification from The NASDAQ Stock Market...


Mar 03, 2011, 08:00 ET Insmed Announces European Medicines Agency Acceptance of Its Pediatric Investigation Plan for ARIKACE™ in the Cystic Fibrosis Pseudomonas Indication

Insmed Incorporated (Nasdaq: INSM), a biopharmaceutical company, announced today that the Pediatric Committee of the European Medicines Agency (EMA)...


Mar 02, 2011, 05:15 ET One-for-10 Reverse Stock Split of Insmed Common Stock Becomes Effective

Insmed Incorporated (Nasdaq: INSM), a biopharmaceutical company, announced today that the one-for-10 reverse stock split of Insmed's Common Stock...


Mar 01, 2011, 09:45 ET Insmed Shareholders Approve Conversion of Series B Conditional Convertible Preferred Stock and Reverse Stock Split

Insmed Incorporated (Nasdaq: INSM), a biopharmaceutical company, announced today that Insmed's shareholders approved the proposal relating to the...


Feb 24, 2011, 08:00 ET Insmed to Participate on Phase III and Beyond Panel at 2011 RBC Capital Markets Healthcare Conference

Insmed Incorporated (Nasdaq: INSM), a biopharmaceutical company, announced today that Timothy Whitten, President & CEO of Insmed, will participate on ...


Feb 23, 2011, 08:00 ET Insmed to Host Fourth Quarter and 2010 Year-End Earnings Conference Call

Insmed Incorporated (Nasdaq: INSM), a biopharmaceutical company, announced today that it will host a conference call on Thursday, March 10th, 2011,...


Dec 16, 2010, 04:15 ET NASDAQ Grants Insmed Incorporated 180-Day Extension to Regain Compliance with Minimum Bid Price Rule

Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company, announced today that it had received a letter, dated December 16, 2010, from The...


Dec 02, 2010, 07:00 ET Insmed Incorporated and Transave, Inc. Announce Business Combination

Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company, announced today that it has entered into a business combination, effective...


Jun 21, 2010, 04:15 ET Insmed Receives NASDAQ Deficiency Notice Relating to Minimum Bid Price

Insmed Incorporated (NASDAQ CM: INSM), a biopharmaceutical company, today announced that on June 18, 2010 it received a NASDAQ Staff Deficiency...


Mar 15, 2010, 07:00 ET Insmed Announces Fourth Quarter and Full-Year 2009 Financial Results

Insmed Inc. (Nasdaq: INSM), a biopharmaceutical company, today reported results for the fourth quarter and full-year ended December 31, 2009....


Mar 04, 2010, 08:00 ET Insmed Regains NASDAQ Compliance

Insmed Incorporated (Nasdaq: INSM), a biopharmaceutical company, today announced that it has received notification from The NASDAQ Stock Market that...


Mar 03, 2010, 08:00 ET Insmed to Host Fourth Quarter and Full-Year 2009 Conference Call

Insmed Inc. (Nasdaq: INSM), a biopharmaceutical company, today announced that it will host a conference call on Monday, March 15th, at 8:30 AM ET, to ...